Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2023 13:30 ET | Source: Mendus AB

Mendus presenterar positiva överlevnadsdata från fas 2-studien ADVANCE II som utvärderar vididencel som underhållsbehandling vid AML vid ASH-konferensen

Pressmeddelande Stockholm, 11 december 2023 Per den 24 november 2023 var återfallsfri medianöverlevnad (mRFS) 30,4 månader Medianen för totalöverlevnad (mOS) hade inte ännu inte uppnåtts, med...
December 11, 2023 13:30 ET | Source: Mendus AB

Mendus announces positive survival data from Phase 2 ADVANCE II trial evaluating vididencel as maintenance therapy for AML at ASH 2023

Press Release Stockholm, Sweden, December 11, 2023 As of November 24, 2023, median relapse-free survival (mRFS) stood at 30.4 months Median overall survival (mOS) was not reached, with the...
June 11, 2021 03:03 ET | Source: Immunicum AB

Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress

Immunicum presenterar data från det kliniska programmet DCP-001 vid European Hematology Association (EHA) 2021 Virtual Congress - Den pågående ADVANCE-II-studien, som utvärderar DCP-001 hos...
June 11, 2021 03:03 ET | Source: Immunicum AB

Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress

Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress -- Ongoing ADVANCE II study evaluating DCP-001 in AML patients is nearing...